Lords Mark Industries Unlisted Shares
Lord’s Mark Industries Ltd – ₹200 Crore Rights Issue & ESOP Approval Post NCLT Scheme
SCANX
2 min read
Expert Analysis:
Lord’s Mark Industries’ fifth Monitoring Committee meeting (3 Jan 2026) approved a rights issue of up to ₹200 crore, to be launched after BSE trading resumes, with promoters allowed to renounce their rights in favour of other investors, signalling intent to broad‑base the shareholder base alongside growth funding.
The committee reviewed NCLT‑ordered capital restructuring, including allotment of 42.66 crore shares at a 1.25:1 swap ratio to eligible shareholders of Lord’s Mark Industries Pvt Ltd and extinguishment of ex‑promoter holdings plus up to 5% proportionate reduction in large public holdings, aimed at cleaning up and realigning the capital structure before relisting.
A new ESOP pool of at least 2% of equity (on the 42.66 crore share base) was cleared to attract senior talent for the company’s push into renal care and med‑tech (via RenalX acquisition, AI‑based dialysis machines and remote monitoring platform), indicating a pivot toward higher‑tech, higher‑margin healthcare businesses.
Key Takeaway:
The combination of NCLT‑driven capital reset, sizeable rights issue, and targeted ESOP for healthcare expansion suggests Lord’s Mark is positioning for a cleaner balance sheet and growth relisting story; actual investor appeal will depend on rights pricing, post‑merger financials, and execution in the new renal/med‑tech verticals once trading resumes on BSE.
Precize Daily Pulse
The latest news in the world of Unlisted Shares, summarised by our experts.
Company
Our Office
Office No. 1219, The Summit Business Park, Andheri Kurla Road, Andheri East, Mumbai, Maharashtra - 400093
Find us on Googlesupport@precize.in
+91 7738336457
All trademarks and logos or registered trademarks and logos found on this Site or mentioned herein belong to their respective owners and are solely used for informational and educational purposes.
The material presented in this advertisement is for informational purposes only and should not be construed as investment advice or investment availability. It is not a recommendation of, or an offer to sell or solicitation of an offer to buy, any particular unlisted share, security, strategy, or investment product. Investing in the private market and securities involves risks, including the potential loss of money, and past performance does not guarantee future results. Market trends, data interpretations, graph projections are provided for informational and illustrative purposes and may not reflect actual future performance. Nothing on this website should be construed as personalized investment advice or should not be treated as legal, financial, or any other form of advice. Precize is not liable for financial or any other form of loss incurred by the user or any affiliated party based on information provided herein.
Precize is neither a stock exchange nor does it intend to get recognized as a stock exchange under the Securities Contracts Regulation Act, 1956. Precize is not authorized by the capital markets regulator to solicit investments. The securities traded on these platforms are not traded on any regulated exchange.
The website will be updated regularly.
Copyright © 2026 - Precize - All Rights Reserved